Martin Sanda
Professor & Chair, Department of Urology, Emory University School of Medicine · Emory University School of Medicine
Credentials: · · · ·
History
- Present
Department of Urology · Emory University School of Medicine
- 1990–1991
- 1989–1991
1979–1983
Research
The polycomb group protein EZH2 is involved in progression of prostate cancer
Nature · 2002 · 2,224 citations
Quality of life and satisfaction with outcome among prostate-cancer survivors
New England Journal of Medicine · 2008 · First of 20 authors · Corresponding · 1,833 citations
Urology · 2000 · Last of 5 authors · 1,300 citations
63 papers
- HS
32 papers
- MR
28 papers
- JM
23 papers
17 papers · 3 as a fellow
16 papers · 2 as a resident
15 papers
15 papers
Grants
- 2005–2028
National Cancer Institute · U01
Contact PI · $16.4M · Emory University
- 2009–2012
Effectiveness of Robotic Compared to Standard Prostatectomy for Prostate Cancer
National Institute of Biomedical Imaging and Bioengineering · RC1
Contact PI · $1M · Beth Israel Deaconess Medical Center
- 2009–2012
Effectiveness of Early Stage Prostate Cancer Treatment
National Cancer Institute · RC1
Contact PI · $996.2K · Beth Israel Deaconess Medical Center
- 2002–2009
Survivor QOL/Spouse Satisfaction After Prostate Therapy
National Cancer Institute · R01
Contact PI · $3.3M · Beth Israel Deaconess Medical Center
Clinical trials
- 2010–2024
Effectiveness of Open and Robotic Prostatectomy
Principal investigator · Completed
Beth Israel Deaconess Medical Center
- 2008–2032
- 2007–2013
Observation or Radical Treatment in Patients With Prostate Cancer
Study chair · Terminated
NCIC Clinical Trials Group
- 2007–2021
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Study chair · Completed
Accuray Incorporated